WST
West Pharmaceutical Services Inc
NYSE: WST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$297.59
+0.76% today
Updated 2026-04-30
Market cap
$20.64B
P/E ratio
39.05
P/S ratio
6.41x
EPS (TTM)
$7.48
Dividend yield
0.28%
52W range
$202 – $322
Volume
0.9M
West Pharmaceutical Services Inc (WST) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $823.60M | $918.20M | $1.19B | $1.17B | $1.27B | $1.29B | $1.40B | $1.56B | $1.67B | $1.67B | $1.70B | $1.72B | $1.86B | $1.59B | $2.34B | $2.79B | $3.31B | $3.62B | $3.83B | $3.64B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $237.20M | $281.70M | $412.30M | $366.20M | $397.20M | $436.60M | $472.00M | $557.30M | $650.70M | $659.30M | $673.70M | $641.90M | $743.50M | $894.40M | $1.06B | $1.37B | $1.74B | $1.92B | $1.94B | $1.54B |
| Total liabilities | $489.50M | $498.90M | $694.70M | $681.60M | $691.90M | $668.60M | $744.20M | $835.10M | $765.20M | $712.80M | $671.20M | $599.20M | $197.00M | $582.60M | $768.20M | $939.30M | $978.40M | $931.90M | $948.50M | $961.10M |
| Current liabilities | $124.80M | $156.90M | $182.90M | $159.10M | $171.10M | $169.70M | $243.20M | $261.80M | $236.90M | $252.50M | $314.30M | $241.00M | $279.50M | $283.70M | $341.60M | $503.40M | $594.10M | $519.00M | $671.80M | $550.40M |
| Long-term debt | $280.70M | $235.80M | $394.60M | $382.10M | $379.10M | $358.10M | $299.30M | $378.80M | $371.30M | $309.50M | $228.90M | $226.20M | $197.00M | $196.00M | $255.00M | $252.90M | $208.80M | $206.70M | $72.80M | $202.60M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $318.60M | $375.70M | $450.30M | $517.30M | $569.40M | $612.60M | $664.50M | $719.90M | $805.00M | $902.20M | $964.60M | $1.07B | $1.18B | $1.35B | $1.55B | $1.85B | $2.46B | $2.99B | $3.52B | $3.96B |
| Accounts receivable | $110.50M | $110.50M | $136.10M | $128.60M | $138.70M | $126.40M | $147.20M | $175.00M | $185.70M | $179.00M | $181.40M | $200.50M | $253.20M | $288.20M | $319.30M | $385.30M | $489.00M | $507.40M | $512.00M | $552.50M |
| Inventory | $61.20M | $97.50M | $111.80M | $115.70M | $129.20M | $147.00M | $151.80M | $162.20M | $176.90M | $181.50M | $181.10M | $199.30M | $215.20M | $214.50M | $235.70M | $321.30M | $378.40M | $414.80M | $434.70M | $377.00M |
| Goodwill | $89.50M | $102.80M | $109.20M | $105.30M | $114.20M | $112.50M | $111.50M | $112.50M | $114.20M | $108.60M | $104.60M | $103.00M | $107.70M | $105.80M | $107.80M | $111.10M | $109.90M | $107.30M | $108.50M | $106.10M |